Bio Medica Lab

Which are the latest news on Bio Medica Lab?

Why is Bio Medica Laboratories Ltd falling/rising?

As of 05-Sep, Bio Medica Laboratories Ltd's stock price is at 177.00, up 9.06%, outperforming the Sensex and showing strong bullish trends across various moving averages. Despite a decrease in investor participation, positive sentiment remains around the stock.

As of 05-Sep, Bio Medica Laboratories Ltd's stock price is rising, currently at 177.00, reflecting an increase of 14.7 or 9.06%. This upward movement is supported by the stock's performance over the past week, where it has outperformed the benchmark Sensex, gaining 20.78% compared to the Sensex's decline of 1.15%. Additionally, the stock has shown strong performance over the past month, with a rise of 13.50%, while the Sensex has decreased by 2.91%.<BR><BR>The stock is also trading above its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a strong bullish trend. Furthermore, today's performance has outpaced the sector by 9.51%. However, it is worth noting that there has been a decrease in investor participation, with delivery volume falling by 13.98% against the 5-day average. Despite this decline in participation, the overall indicators suggest a positive sentiment around Bio Medica Laboratories Ltd, contributing to its rising stock price.

What does Bio Medica Lab do?

Bio Medica Laboratories Ltd is a Micro Cap company in the Pharmaceuticals & Biotechnology industry, incorporated in 2015. It has a market cap of INR 184 Cr, a P/E ratio of 16.00, and a return on equity of 79.21%, but lacks recent sales and profit data.

Overview:<BR>Bio Medica Laboratories Ltd operates in the Pharmaceuticals & Biotechnology industry and is classified as a Micro Cap company.<BR><BR>History:<BR>Bio Medica Laboratories Limited was originally incorporated as a private limited company under the name "Bio Medica Laboratories Private Limited" on August 14, 2015, by the Registrar of Companies in Gwalior. There is no information available regarding status changes or the latest quarter for which sales and profit are reported.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 184 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 16.00<BR>Industry P/E: 37<BR>Dividend Yield: 0.00%<BR>Debt-Equity: 1.02<BR>Return on Equity: 79.21%<BR>Price-to-Book: 12.51<BR><BR>Contact Details:<BR>Registrar Address: Not available<BR>Phone: N/A<BR>Email: N/A<BR>Website: N/A

Who are the peers of the Bio Medica Lab?

Bio Medica Lab's peers include Accretion Pharma, Sat Kartar Life, Brooks Lab, CCME Global, Syschem (India), Oxygenta Pharma, Achyut Healthcare, and Smruthi Organic. Management and growth risks vary, with Sat Kartar Life showing excellent ratings, while Accretion Pharma leads in 1-year returns.

Peers: The peers of Bio Medica Lab are Accretion Pha., Sat Kartar Life, Brooks Lab., CCME Global, Syschem (India), Oxygenta Pharma, Achyut Healthcar, and Smruthi Organic.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sat Kartar Life, while Good management risk is found at Accretion Pha. and the rest. Below Average management risk is noted for Brooks Lab., CCME Global, Syschem (India), Achyut Healthcar, and Smruthi Organic. Growth is Excellent at Sat Kartar Life and Accretion Pha., while Good growth is seen at Syschem (India) and Average growth at Achyut Healthcar. Below Average growth is reported for Brooks Lab., CCME Global, Oxygenta Pharma, and Smruthi Organic. Capital Structure ratings show Excellent at Sat Kartar Life, Good at Accretion Pha., Syschem (India), Achyut Healthcar, and Smruthi Organic, while Below Average is noted for Brooks Lab. and CCME Global, and Oxygenta Pharma does not qualify.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Accretion Pha. with N/A, while the peer with the lowest is Sat Kartar Life at -26.77%, and Bio Medica Lab's 1-year return is also N/A. Additionally, peers with negative six-month returns include Sat Kartar Life and Brooks Lab.

How big is Bio Medica Lab?

As of 14th August, Bio Medica Laboratories Ltd has a market capitalization of 184.00 Cr, classified as a Micro Cap, with no valid financial data available for Net Sales or Net Profit for the latest four quarters. The balance sheet as of March 2025 shows Shareholder's Funds of 14.73 Cr and Total Assets of 38.90 Cr.

As of 14th August, <BR><BR>Market Cap: Bio Medica Laboratories Ltd has a market capitalization of 184.00 Cr, classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales or Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2025, with Shareholder's Funds amounting to 14.73 Cr and Total Assets valued at 38.90 Cr.